Inflammation mediates the association between the triglyceride-glucose index and non-target lesions progression after PCI: a cohort study
Open Access
- 10 March 2026
- journal article
- research article
- Published by Springer Nature in Lipids in Health and Disease
- Vol. 25 (1)
Abstract
The progression of non-target lesions (NTLs) following percutaneous coronary intervention (PCI) is an important clinical issue, yet the role of triglyceridKeywords
This publication has 41 references indexed in Scilit:
- Clinical impact of systemic inflammation across different high-sensitivity C-reactive protein cutoffs in patients undergoing percutaneous coronary interventionAtherosclerosis, 2025
- Association of the triglyceride-glucose index with risk of depression and anxiety: A prospective cohort studyJournal of Affective Disorders, 2025
- MAFLD as a predictor of adverse cardiovascular events among CHD patients with LDL-C<1.8 mmol/LNutrition, Metabolism and Cardiovascular Diseases, 2024
- Non-target lesion progression: Unveiling critical predictors and outcomes in patients with in-stent restenosisInternational Journal of Cardiology, 2024
- Impact of triglyceride-glucose index on intracoronary thrombus burden in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary interventionNutrition, Metabolism and Cardiovascular Diseases, 2024
- 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary DiseaseJACC, 2023
- Effects of Xinkeshu tablets on coronary heart disease patients combined with anxiety and depression symptoms after percutaneous coronary intervention: A meta-analysisPhytomedicine, 2022
- IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trialThe Lancet, 2021
- Nonculprit Lesion Myocardial Infarction Following Percutaneous Coronary Intervention in Patients With Acute Coronary SyndromeJACC, 2020
- Association Between Adoption of Evidence-Based Treatment and Survival for Patients With ST-Elevation Myocardial InfarctionJAMA, 2011